Bioanalytical Services
Lovelace Biomedical is your partner in quantitative analysis throughout drug development. Regardless of the stage of your program Lovelace Biomedical has the experience needed to develop, transfer, and validate methods and perform sample analysis. Lovelace has extensive expertise in quantitative bioanalysis to support pharmacokinetic, toxicokinetic, biomarker and immunology end point across a complete range of assay formats. This includes specialized laboratories and experienced bioanalytical subject matter experts to serve as your partner. Whether working with a small molecule, large molecule, cell and gene therapy or biomarkers Lovelace Biomedical can collaborate with you to meet your program needs.
Lovelace can support programs that utilize in vivo studies at Lovelace or at other sites. These methods can support pharmacokinetic, toxicokinetic, biodistribution, and in vivo metabolism studies. The analyses can be conducted to evaluate parent molecules or metabolites in a full range of matrices, including blood, plasma, serum, urine, CSF, pleural fluid and tissue. Whether your study is an exploratory research study or a GLP toxicology study Lovelace has the Bioanalytical team to support your needs.
Capabilities
Our Analytical/Bioanalytical Services Department provides a state-of-the-art infrastructure with experience in quantitative analysis to support dose formulation, aerosol characterization, pharmacokinetic, toxicokinetic, and biomarker sample analysis. Methods can be transferred or developed de novo. Methods can be validated to meet regulatory compliance or utilized in non-regulatory drug development. Analytes can include small molecules, proteins, mAb, cytokines, biomarkers, or peptides. Capabilities include:
- Quantitative analysis
- Development/transfer of bioanalytical assays
- Validation of methods
- GLP compliance
- LC-MS, ELISA, MSD, PCR, Flow Cytometry platforms
- Multiple analytes
- Endogenous analytes
- Immunology, Cell-based Assays
- Flow Cytometry